APOE and COVID-19: To investigate, if APOE4 carriers that died from COVID‐19 in the first wave of infections in early 2020 show increased neuro‐inflammation, we determined the APOE genotype from archival tissue in paraffin blocks and assessed the microglia abundance and morphology using immune‐histochemical staining of HLA‐DR/DQ/DP.